bw 373u86 has been researched along with naltrindole in 14 studies
| Studies (bw 373u86) | Trials (bw 373u86) | Recent Studies (post-2010) (bw 373u86) | Studies (naltrindole) | Trials (naltrindole) | Recent Studies (post-2010) (naltrindole) |
|---|---|---|---|---|---|
| 80 | 0 | 4 | 801 | 0 | 139 |
| Protein | Taxonomy | bw 373u86 (IC50) | naltrindole (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.0007 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.0006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (64.29) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernard, D; Coop, A; MacKerell, AD | 1 |
| Moerschbaecher, JM; Pakarinen, ED; Woods, JH | 1 |
| Butelman, ER; Chang, KJ; DeCosta, B; Negus, SS; Winger, G; Woods, JH | 1 |
| Borsodi, A; Chang, KJ; Fang, L; McNutt, RW; Porreca, F; Toth, G; Wild, KD; Yamamura, HI | 1 |
| Chang, KJ; Dykstra, LA; McNutt, R; Schoenbaum, GM; Yarbrough, J | 1 |
| Cook, CD; Morgan, D; Negus, SS; Picker, MJ | 1 |
| Cozzolino, A; Di Chiara, G; Giagheddu, M; Marrosu, F; Puligheddu, M | 1 |
| Kapusta, DR; Kenigs, VA; Sezen, SF | 1 |
| Cadoni, C; Di Chiara, G; Longoni, R; Mulas, A; Spina, L | 1 |
| Chang, KJ; McNutt, RW; Su, YF | 1 |
| Fiore, P; Gannon, RL; Tierno, A | 1 |
| Folk, JE; Isgor, C; Rice, KC; Torregrossa, MM; Watson, SJ; Woods, JH | 1 |
| Jutkiewicz, EM; Ko, MC; Rice, KC; Shi, YG; Torregrossa, MM; Watson, SJ; Woods, JH; Zhang, H | 1 |
| Chai, W; Ding, Q; Gao, C; Sun, M; Sun, X; Yang, L; Yao, L; Yu, D; Zhao, X | 1 |
14 other study(ies) available for bw 373u86 and naltrindole
| Article | Year |
|---|---|
Quantitative conformationally sampled pharmacophore for delta opioid ligands: reevaluation of hydrophobic moieties essential for biological activity.
Topics: Animals; Cell Line, Tumor; Enkephalin, Leucine; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Molecular Conformation; Phenylalanine; Quantitative Structure-Activity Relationship; Rats; Receptors, Opioid, delta | 2007 |
Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzamides; Conditioning, Operant; Dose-Response Relationship, Drug; Female; Morphine; Naltrexone; Piperazines; Pyrrolidines; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Saimiri | 1995 |
Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys.
Topics: Analgesics; Animals; Behavior, Animal; Benzamides; Female; Macaca mulatta; Male; Naltrexone; Narcotic Antagonists; Piperazines; Receptors, Opioid, delta; Respiration | 1994 |
Binding of BW 373U86, a non-peptidic delta opioid receptor agonist, is not regulated by guanine nucleotides and sodium.
Topics: Animals; Benzamides; Binding, Competitive; Brain; Guanine Nucleotides; Male; Membranes; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Piperazines; Radioligand Assay; Receptors, Opioid, delta; Sodium; Vas Deferens | 1993 |
A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration.
Topics: Amino Acid Sequence; Animals; Behavior, Animal; Benzamides; Drug Interactions; Drug Tolerance; Electroshock; Male; Methadone; Molecular Sequence Data; Naltrexone; Narcotic Antagonists; Nociceptors; Piperazines; Receptors, Opioid, delta; Receptors, Opioid, mu; Saimiri | 1993 |
Effects of the delta opioid against BW373U86 in pigeons trained to discriminate fentanyl, bremazocine and water in a three-choice drug discrimination procedure.
Topics: Analgesics; Animals; Benzamides; Benzomorphans; Columbidae; Discrimination, Psychological; Female; Fentanyl; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Piperazines; Receptors, Opioid, delta | 1996 |
Hippocampal theta activity after systemic administration of a non-peptide delta-opioid agonist in freely-moving rats: relationship to D1 dopamine receptors.
Topics: Animals; Benzamides; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Hippocampus; Locomotion; Naltrexone; Narcotic Antagonists; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Opioid, delta; Theta Rhythm | 1997 |
Renal excretory responses produced by the delta opioid agonist, BW373U86, in conscious rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzamides; Denervation; Infusions, Intravenous; Kidney; Male; Naltrexone; Oligopeptides; Opioid Peptides; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta | 1998 |
Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 2. Place-preference and brain microdialysis studies in rats.
Topics: Animals; Behavior, Animal; Benzamides; Benzazepines; Brain Chemistry; Caudate Nucleus; Conditioning, Operant; Dopamine; Dopamine Antagonists; Extracellular Space; Male; Microdialysis; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Piperazines; Rats; Rats, Sprague-Dawley | 1998 |
Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception.
Topics: Alfentanil; Analgesics, Opioid; Animals; Benzamides; Hypercapnia; Ligands; Male; Naltrexone; Narcotic Antagonists; Narcotics; Oligopeptides; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Respiration; Respiratory Insufficiency; Somatostatin | 1998 |
Delta opioid inhibition of light-induced phase advances in hamster circadian activity rhythms.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzamides; Biological Clocks; Circadian Rhythm; Cricetinae; Enkephalins; Light; Male; Mesocricetus; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Nerve Tissue Proteins; Opioid Peptides; Piperazines; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Suprachiasmatic Nucleus | 2002 |
The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Benzamides; Brain; Brain-Derived Neurotrophic Factor; Bupropion; Desipramine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Tolerance; Gene Expression Regulation; Immobilization; In Situ Hybridization; Male; Midazolam; Naltrexone; Narcotic Antagonists; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, trkB; Receptors, Opioid, delta; RNA, Messenger; Swimming; Time Factors; Up-Regulation | 2004 |
Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects.
Topics: Analgesics, Opioid; Analysis of Variance; Animals; Autoradiography; Behavior, Animal; Benzamides; Brain-Derived Neurotrophic Factor; Dose-Response Relationship, Drug; Drug Interactions; Freezing Reaction, Cataleptic; In Situ Hybridization; Injections, Intraventricular; Male; Naltrexone; Narcotics; Opioid Peptides; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; RNA, Messenger; Swimming; Up-Regulation | 2006 |
Delta opioid receptor agonist BW373U86 attenuates post-resuscitation brain injury in a rat model of asphyxial cardiac arrest.
Topics: Animals; Asphyxia; Benzamides; Blotting, Western; Brain Damage, Chronic; Cardiopulmonary Resuscitation; CREB-Binding Protein; Disease Models, Animal; Heart Arrest; Immunoenzyme Techniques; Male; Naltrexone; Neuroprotective Agents; Piperazines; Rats, Sprague-Dawley | 2014 |